Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: A prospective randomized double-blind study

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 12, 2001, Pages 1332-1338

  Udd, M ^a   Miettinen, P ^a   Palmu, A ^a   Heikkinen, M ^a   Janatuinen, E ^a   Pasanen, P ^a   Tarvainen, R ^a   Kairaluoma, M V ^a   Lohman, M ^a   Mustonen, H ^a   Julkunen, R ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bleeding; Endoscopic treatment; Omeprazole; Peptic ulcer; Rebleeding

Indexed keywords

OMEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME;

AGED; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DUODENAL ULCER; FEMALE; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER HEMORRHAGE; PROSPECTIVE STUDIES; STOMACH ULCER;

EID: 17944382828     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201317097218     Document Type: Article

References (30)

1. Endoscopic prediction of major rebleeding - A prospective study of stigmata of hemorrhage in bleeding ulcer
2. Prediction of further hemorrhage in bleeding peptic ulcer
3. Factors predisposing to further hemorrhage and mortality after peptic ulcer bleeding
4. Hypotension and endoscopic stigmata of recent haemorrhage in bleeding peptic ulcer: Risk models for bleeding and mortality
5. The visible vessel as an indicator of uncontrolled or recurrent gastrointestinal hemorrhage
6. Impact of endoscopic therapy on outcome of operation for bleeding peptic ulcers
7. Controlled trial of small bipolar probe in bleeding peptic ulcers
8. Heat probe thermocoagulation and pure alcohol injection in massive peptic haemorrhage. A prospective randomised controlled trial
9. Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer
10. Endoscopic haemostasis. An effective therapy for bleeding peptic ulcers
11. Effect of acid and pepsin on blood coagulation and platelet aggregation
12. Effect of intravenous and oral omeprazole on 24 hour intragastric acidity in duodenal ulcer patients
13. Effect of intravenous omeprazole on twenty-four-hour intragastric pH in patients with a history of peptic ulcer
14. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?
15. Effect of once daily intravenous and oral omeprazole on 24 hour intragastric acidity in healthy subjects
16. Repeated intravenous bolus injections of omeprazole: Effects of 24-hour intragastric pH, serum gastrin and serum pepsinogen A and C
17. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study
18. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of placebo-controlled multicenter study
19. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers
20. Comparison of two doses of intravenous pantoprazole in peptic ulcer bleeding
21. Endoscopy in gastrointestinal bleeding
22. Significance testing to establish equivalence between treatments with special reference to data in the form of 2 × 2 tables
23. Bleeding peptic ulcer. Epidemiology and non-surgical management
24. Non-bleeding visible vessel treatment: Perendoscopic injection therapy versus omeprazole infusion
25. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: A prospective randomised study
26. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with peptic ulcer bleeding after successful endoscopic therapy
27. A comparison of omeprazole and placebo for bleeding peptic ulcer
28. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer
29. Failures of endoscopic therapy for bleeding peptic ulcer: An analysis of risk factors